Increasing Prevalence of Cardiovascular Diseases to Augment Growth of Acute Heart Failure (AHF) Therapeutics Market

 

Acute heart failure is a medical emergency that involves sudden, permanent cessation of cardiac function (also called ventricular fibrillation). Acute heart failure most often develops due to a rupture or leaky blood vessel somewhere in the heart. This can happen either at the heart site itself, such as at the coronary artery, or at the lung level, such as at the aortic valve. As a result of the rupture, blood is pooling at the heart site and the blood flow is markedly reduced. As this pooling continues, blood pressure drops causing a decrease in cardiac output and, as the problem worsens, shock and death occur.

Market Dynamics

Increasing prevalence of cardiovascular diseases is expected to propel growth of the global acute heart failure (AHF) therapeutics market. For instance, according to the American Heart Association's Heart and Stroke Statistics 2020 Update, by 2035, 45.1% of the U.S population is projected to have some form of cardiovascular disease. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to United Nations Population Fund, geriatric population in Asia Pacific is expected to triple between 2010 and 2050 to reach 1.3 billion people by 2050.

High prevalence of heart failure is also expected to propel growth of the global acute heart failure (AHF) therapeutics market. For instance, according to the study, ‘Global epidemiology and future trends of heart failure’, published in AME Medical Journal in June 2020, heart failure poses the largest burden after 60 years of age and both prevalence and YLDs have increased by 3.9% and 4.5% in very elderly people during the last 28 years. Moreover, R&D in acute heart failure (AHF) therapeutics is also expected to aid in growth in the market. For instance, in November 2020, a clinical trial by Brigham and Women's Hospital and sponsored by Lexicon Pharmaceuticals, a biopharmaceutical company based in the U.S., reported that sotagliflozin, a combination sodium/glucose cotransporter 1 and 2 (SGLT1/2) inhibitor, resulted in a lower risk of the composite of deaths from cardiovascular causes, hospitalizations for heart failure, and urgent visits for heart failure than placebo.

Competitive Analysis

Major players operating in the acute heart failure (AHF) therapeutics market include, Novartis AG, Cardiorentis AG, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Cytokinetics, Inc., Merck & Company, Inc., Ono Pharmaceutical Co., Ltd., and Pfizer Inc., among others.


Location: India

Comments

Post a Comment

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

Image
  Fitness equipment is any mechanical device or equipment used in sport or exercise to improve the physical performance or strength of that activity by providing either adjustable or constant levels of force, either of dynamic nature that is immediately available to exert (such as running) or of a static type that requires adjustments (such as a bicycle). Some common types of equipment are treadmills, elliptical machines, step machines, exercise bicycles, recumbent bikes, treadmill monitors, rowing machines, and many more. Fitness equipment is used in gyms and private home fitness facilities as well as public parks and recreational facilities. Fitness equipment for the home is designed to provide low-impact aerobic workouts. Some items are available for rent or sale on the Internet. Rowing machines and exercise bicycles can give an all-over body workout, while Schwinn exercise bicycles can be used to target specific muscles. Fitness equipment for home gyms can be classified into card
Read more

The market for ureteral stents would benefit from the rising prevalence of urological diseases

Image
  A ureteral stent is a slender adaptable cylinder embedded straightforwardly into the ureter to forestall or cure block of the urinary entry from the ureter. The length of these stents utilized for grown-up quiet's reaches somewhere in the range of 30 and 24 inches. Furthermore, various distances across or sizes of stents are accessible, to suit distinctive ureter sizes. This permits treatment choices to be customized to the person, just as to the degree of obstacle. Urinary stents are made of either metal silicone or plastic. They are set straightforwardly into the bladder through the urethra valve. Ureteral stents can either be made percutaneously, through medical procedure or by methods for an outpatient strategy. Contingent upon the sort of ureter that is influenced, the technique can be either a solitary needle or numerous needles. The developing commonness of urological illnesses around the world is driving the development of the ureteral stents market . Development in t
Read more

The North America Vision Care Market Is Driven by the Increasing Prevalence of Eye Diseases in this Region

Image
  Vision care refers to the prevention and treatment of various eye conditions or eye diseases, such as refractive errors, age-related macular degeneration, cataract, glaucoma, etc. Vision care helps prevent or minimize the threat to eyes or visual integrity. Therefore, in North America, demand for vision care is has increased due the increasing prevalence of eye diseases, driving the North America vision care market growth. According to the Centers for Disease Control and Prevention (CDC), cataract affects around 24.4 million Americans (aged 40 and older) or around one in every six people in this age group. Vision care is important because 80% of what we perceive comes through our sense of sight. By protecting the eyes, people can reduce the odds of vision loss or blindness while also staying on top of any developing eye diseases such as glaucoma and cataracts. Vision care products used for restoration of eye sights include contact lenses, reading glasses, frames, Rx-Lenses, non Rx-
Read more